These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26180837)

  • 41. Mastitis due to Mycobacterium avium complex in an HIV-infected woman taking highly active antiretroviral therapy.
    Cunningham CO; Selwyn PA
    AIDS Patient Care STDS; 2003 Nov; 17(11):547-50. PubMed ID: 14746662
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prophylaxis against Mycobacterium avium-intracellulare complex infections in human immunodeficiency virus-infected patients.
    Nightingale SD
    Infection; 1997; 25(1):67-70. PubMed ID: 9039547
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disseminated Mycobacterium avium infection among HIV-infected patients in Kenya.
    Gilks CF; Brindle RJ; Mwachari C; Batchelor B; Bwayo J; Kimari J; Arbeit RD; von Reyn CF
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Feb; 8(2):195-8. PubMed ID: 7834402
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cerebral Mycobacterium avium abscesses: Late immune reconstitution syndrome in an HIV-1-infected patient receiving highly active antiretroviral therapy.
    Fortin C; Rouleau D
    Can J Infect Dis Med Microbiol; 2005 May; 16(3):187-9. PubMed ID: 18159542
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of disseminated Mycobacterium avium-complex infection on survival of HIV-infected patients.
    Brodt HR; Enzensberger R; Kamps BS; Keul HG; Helm EB
    Eur J Med Res; 1997 Mar; 2(3):106-10. PubMed ID: 9113499
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mycobacterium avium complex infection-related immune reconstitution inflammatory syndrome of the central nervous system in an HIV-infected patient: case report and review.
    Lee YC; Lu CL; Lai CC; Tseng YT; Sun HY; Hung CC
    J Microbiol Immunol Infect; 2013 Feb; 46(1):68-72. PubMed ID: 22227308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impaired erythropoiesis in the acquired immunodeficiency syndrome with disseminated Mycobacterium avium complex.
    Gascón P; Sathe SS; Rameshwar P
    Am J Med; 1993 Jan; 94(1):41-8. PubMed ID: 8093587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of Mycobacterium avium complex prophylaxis on the incidence of mycobacterial infections and transfusion-requiring anemia in an HIV-positive population.
    Kravcik S; Toye BW; Fyke K; Hawley-Foss N; Fillion D; Yurack JA; Cameron DW
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Sep; 13(1):27-32. PubMed ID: 8797683
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Azithromycin prophylaxis for Mycobacterium avium complex during the era of highly active antiretroviral therapy: evaluation of a provincial program.
    Phillips P; Chan K; Hogg R; Bessuille E; Black W; Talbot J; O'Shaughnessy M; Montaner J
    Clin Infect Dis; 2002 Feb; 34(3):371-8. PubMed ID: 11774085
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [AIDS-related Mycobacterium avium infection dissemination in a patient with endobronchial lesions associated with immune reconstitution inflammatory syndrome].
    Ogawa E; Murata M; Ohnishi H; Tatsukawa M; Sawayama Y; Furusyo N; Hayashi J
    Kansenshogaku Zasshi; 2008 Jul; 82(4):341-6. PubMed ID: 18697487
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimating the frequency of tap-water exposures to Mycobacterium avium complex in the U.S. population with advanced AIDS.
    Rice G; Wright JM; Boutin B; Swartout J; Rodgers P; Niemuth N; Broder M
    J Toxicol Environ Health A; 2005 Jun 11-25; 68(11-12):1033-47. PubMed ID: 16020190
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discontinuation of primary prophylaxis against Mycobacterium avium complex infection in HIV-infected persons receiving antiretroviral therapy: observations from a large national cohort in the United States, 1992-2002.
    Brooks JT; Song R; Hanson DL; Wolfe M; Swerdlow DL;
    Clin Infect Dis; 2005 Aug; 41(4):549-53. PubMed ID: 16028167
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of subclinical Mycobacterium avium intracellulare complex infection in immunodeficient HIV-infected patients treated with zidovudine.
    Mallal SA; James IR; French MA
    AIDS; 1994 Sep; 8(9):1263-9. PubMed ID: 7802978
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mycobacterium avium complex in the respiratory or gastrointestinal tract and the risk of M. avium complex bacteremia in patients with human immunodeficiency virus infection.
    Chin DP; Hopewell PC; Yajko DM; Vittinghoff E; Horsburgh CR; Hadley WK; Stone EN; Nassos PS; Ostroff SM; Jacobson MA
    J Infect Dis; 1994 Feb; 169(2):289-95. PubMed ID: 7906290
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Mycobacterium avium infection in HIV-infected patients: epidemiology, diagnosis, prevention and treatment].
    Schneider MM; Reiss P; Borleffs JC; Rozenberg-Arska M; Hoepelman IM
    Ned Tijdschr Geneeskd; 1997 Jan; 141(2):80-3. PubMed ID: 9036351
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HAART and Mycobacterium avium complex in an HIV infected patient with severe factor VII deficiency.
    Girmenia C; Martino P; Mazzucconi MG; Bizzoni L; Cassone A
    Haemophilia; 2000 Mar; 6(2):116-7. PubMed ID: 10781200
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prolonged fever due to Mycobacterium avium complex (MAC) disease in advanced HIV infection: a public health concern.
    Suwanagool S; Kolladarungkri T; Leelarasamee A; Chuenarom V; Jearanaisilavong J; Chaiprasert A
    J Med Assoc Thai; 1998 Nov; 81(11):893-905. PubMed ID: 9803090
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Environmental risk factors for acquisition of Mycobacterium avium complex in persons with human immunodeficiency virus infection.
    Horsburgh CR; Chin DP; Yajko DM; Hopewell PC; Nassos PS; Elkin EP; Hadley WK; Stone EN; Simon EM; Gonzalez P
    J Infect Dis; 1994 Aug; 170(2):362-7. PubMed ID: 7913481
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discontinuation of secondary prophylaxis against disseminated Mycobacterium avium complex infection and toxoplasmic encephalitis.
    Zeller V; Truffot C; Agher R; Bossi P; Tubiana R; Caumes E; Jouan M; Bricaire F; Katlama C
    Clin Infect Dis; 2002 Mar; 34(5):662-7. PubMed ID: 11810599
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of Mycobacterium avium complex immune reconstitution disease in HIV-1-infected individuals.
    Desimone JA; Babinchak TJ; Kaulback KR; Pomerantz RJ
    AIDS Patient Care STDS; 2003 Dec; 17(12):617-22. PubMed ID: 14746655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.